ASRS
ARQT icon

Arizona State Retirement System’s Arcutis Biotherapeutics ARQT Stock Holding History

Arizona State Retirement System’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$808K Buy
30,802
+521
+2% +$12.1K ﹤0.01% 1291
2026
Q1 		$713K Buy
30,281
+413
+1% +$10.5K ﹤0.01% 1289
2025
Q4 		$867K Sell
29,868
-1,817
-6% -$46.5K ﹤0.01% 1190
2025
Q3 		$597K Buy
31,685
+568
+2% +$8.96K ﹤0.01% 1401
2025
Q2 		$436K Buy
31,117
+958
+3% +$13.4K ﹤0.01% 1529
2025
Q1 		$472K Sell
30,159
-329
-1% -$4.63K ﹤0.01% 1452
2024
Q4 		$425K Buy
30,488
+488
+2% +$5.35K ﹤0.01% 1579
2024
Q3 		$279K Buy
30,000
+1,032
+4% +$10.2K ﹤0.01% 1807
2024
Q2 		$269K Buy
+28,968
New +$262K ﹤0.01% 1763
2023
Q4 		– Sell
-13,116
Closed -$69.6K – 2150
2023
Q3 		$69.6K Buy
13,116
+1,106
+9% +$9.41K ﹤0.01% 2121
2023
Q2 		$114K Sell
12,010
-347
-3% -$3.85K ﹤0.01% 2096
2023
Q1 		$136K Buy
12,357
+469
+4% +$6.79K ﹤0.01% 2046
2022
Q4 		$176K Buy
11,888
+680
+6% +$11.9K ﹤0.01% 1962
2022
Q3 		$214K Buy
+11,208
New +$254K ﹤0.01% 1847
2021
Q2 		– Sell
-7,152
Closed -$207K – 2227
2021
Q1 		$207K Buy
+7,152
New +$223K ﹤0.01% 2023

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arizona State Retirement System's ARQT Position: Q2 2026 in Review

Arizona State Retirement System increased its Arcutis Biotherapeutics (ARQT) stake by 1.7% in Q2 2026, buying an estimated $12.1K and bringing the position to 30,802 shares worth $808K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Arizona State Retirement System first reported a position in ARQT in Q1 2021 and has held it in 15 quarters since. The position peaked at $867K in Q4 2025. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Arizona State Retirement System held 30,802 shares of Arcutis Biotherapeutics worth $808K as of Q2 2026.
  • Arizona State Retirement System bought 521 Arcutis Biotherapeutics shares in Q2 2026, an estimated $12.1K.
  • Arcutis Biotherapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1291 holding.
  • Arizona State Retirement System first reported a position in Arcutis Biotherapeutics in Q1 2021 and has held it in 15 quarters since.
  • Arizona State Retirement System's Arcutis Biotherapeutics position peaked at $867K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.